Targeting CXCL12CXCR4 and myeloid cells to improve the therapeutic ratio in patientderived cervical cancer models treated with radiochemotherapy

Targeting CXCL12/CXCR4 and myeloid cells to improve the therapeutic ratio in patient-derived cervical cancer models treated with radio-chemotherapy

00:54 EDT 26 Jun 2019 | Nature Publishing

More From BioPortfolio on "Targeting CXCL12/CXCR4 and myeloid cells to improve the therapeutic ratio in patient-derived cervical cancer models treated with radio-chemotherapy"